| Product Name | MF | CAS | Details |
|---|
| Anti-CLEC4C Reference Antibody (LFB patent anti-BDCA-2) | Details |
| Anti-CLEC7A Reference Antibody (Baylor patent anti-Dectin-1) | Details |
| Anti-Clusterin Reference Antibody (AB-16B5) | Details |
| Anti-Complement C2 Reference Antibody (ARGX-117) | Details |
| Anti-Complement C3 Reference Antibody (NGM621) | Details |
| Anti-Complement C5 Reference Antibody (crovalimab) | Details |
| Anti-Complement C5 Reference Antibody (eculizumab) | Details |
| Anti-Complement C5 Reference Antibody (lendalizumab) | Details |
| Anti-Complement C5 Reference Antibody (pozelimab) | Details |
| Anti-Complement C5 Reference Antibody (ravulizumab) | Details |
| Anti-Complement C5 Reference Antibody (tesidolumab) | Details |
| Anti-Complement C5 Reference Antibody (vilobelimab) | Details |
| Anti-Complement C5aR1 Reference Antibody (avdoralimab) | Details |
| Anti-Complement C5aR1 Reference Antibody (G2 patent anti-C5aR) | Details |
| Anti-Complement C5aR1 Reference Antibody (G2_anti-C5aR) | Details |
| Anti-Complement Factor B Reference Antibody (Genentech patent anti-Factor B) | Details |
| Anti-Complement Factor D Reference Antibody (lampalizumab) | Details |
| Anti-Complement Factor P / Properdin Reference Antibody (Novelmed patent anti-Properdin) | Details |
| Anti-c-RET Reference Antibody (Regeneron patent anti-RET) | Details |
| Anti-CRTAM / CD355 Reference Antibody (Oxford Bio patent anti-CRTAM) | Details |
| Anti-CSF1 / M-CSF Reference Antibody (lacnotuzumab) | Details |
| Anti-CSF1R / M-CSFR / CD115 Reference Antibody (axatilimab) | Details |
| Anti-CSF1R / M-CSFR / CD115 Reference Antibody (cabiralizumab) | Details |
| Anti-CSF1R / M-CSFR / CD115 Reference Antibody (emactuzumab) | Details |
| Anti-CSF1R / M-CSFR / CD115 Reference Antibody (LY3022855) | Details |
| Anti-CSF2 / GM-CSF Reference Antibody (gimsilumab) | Details |
| Anti-CSF2 / GM-CSF Reference Antibody (lenzilumab) | Details |
| Anti-CSF2 / GM-CSF Reference Antibody (namilumab) | Details |
| Anti-CSF2 / GM-CSF Reference Antibody (otilimab) | Details |
| Anti-CSF2 / GM-CSF Reference Antibody (plonmarlimab) | Details |
| Anti-CSF2 / GM-CSF Reference Antibody (Theraclone patent anti-GM-CSF) | Details |
| Anti-CSF2Ra / GM-CSFRa / CD116 Reference Antibody (mavrilimumab) | Details |
| Anti-CSF2Rb / CD131 Reference Antibody (CSL311) | Details |
| Anti-CSF3 / G-CSF Reference Antibody (CSL324) | Details |
| Anti-CSF3R / G-CSFR Reference Antibody (CSL patent anti-G-CSFR) | Details |
| Anti-CTLA-4 / CD152 Reference Antibody (Antitope patent anti-CTLA4) | Details |
| Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab) | Details |
| Anti-CTLA-4 / CD152 Reference Antibody (nurulimab) | Details |
| Anti-CTLA-4 / CD152 Reference Antibody (quavonlimab) | Details |
| Anti-CTLA-4 / CD152 Reference Antibody (tremelimumab) | Details |
| Anti-CTLA-4 / CD152 Reference Antibody (zalifrelimab) | Details |
| Anti-CTLA-8 / IL-17a Antibody (SY18-VHH-11) | Details |
| Anti-CTLA-8 / IL-17a Reference Antibody (CAT-2200) | Details |
| Anti-CTLA-8 / IL-17a Reference Antibody (ixekizumab) | Details |
| Anti-CTLA-8 / IL-17a Reference Antibody (netakimab) | Details |
| Anti-CTLA-8 / IL-17a Reference Antibody (perakizumab) | Details |
| Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab) | Details |
| Anti-CTLA-8 / IL-17a Reference Antibody (UCB patent anti-IL-17) | Details |
| Anti-CTLA-8 / IL-17a Reference Antibody (vunakizumab) | Details |
| Anti-CTSS / Cathepsin S Reference Antibody (Fsn0503h) | Details |
| Anti-CX3CL1 / Fractalkine Reference Antibody (quetmolimab) | Details |
| Anti-CXADR Reference Antibody (Med. Bio. Labs patent anti-CXADR) | Details |
| Anti-CXC-ELR Reference Antibody (Lilly patent anti-Pan-ELR+) | Details |
| Anti-CXCL10 / IP-10 Reference Antibody (eldelumab) | Details |
| Anti-CXCL10 / IP-10 Reference Antibody (NI-0801) | Details |
| Anti-CXCL12 / SDF1a Reference Antibody (Genentech anti-CXCL12) | Details |
| Anti-CXCL4 / PF4 Reference Antibody (U.Penn. patent anti-PF4) | Details |
| Anti-CXCL8 / IL-8 Reference Antibody (ABX-IL8) | Details |
| Anti-CXCL8 / IL-8 Reference Antibody (Genentech patent anti-IL-8) | Details |
| Anti-CXCL8 / IL-8 Reference Antibody (HuMax-IL8) | Details |
| Anti-CXCL9 Reference Antibody (Novimmune patent anti-CXCL9) | Details |
| Anti-CXCR3 / GPR9 / CD183 Reference Antibody (Genzyme patent anti-CXCR3) | Details |
| Anti-CXCR4 / CD184 Reference Antibody (Dana-Farber patent anti-CXCR4) | Details |
| Anti-CXCR4 / CD184 Reference Antibody (ulocuplumab) | Details |
| Anti-CXCR5 / CD185 Reference Antibody (SAR113244) | Details |
| Anti-CYR61 / CCN1 Reference Antibody (Roche patent anti-CCN1) | Details |
| Anti-CLDN18.2 Reference Antibody (zolbetuximab) | Details |
| Anti-CLEC12A / CD371 Reference Antibody (tepoditamab) | Details |
| Anti-CLEC14A Reference Antibody (Scripps Korea patent anti-CLEC14A) | Details |
| Anti-CLEC4C Reference Antibody (BIIB059) | Details |
| Anti-CD7 Reference Antibody (grisnilimAb) | Details |
| Anti-CD7 Reference Antibody (Persongen patent anti-CD7) | Details |
| Anti-CD74 Reference Antibody (milatuzumab) | Details |
| Anti-CD79b Reference Antibody (iladatuzumAb) | Details |
| Anti-CD79b Reference Antibody (polatuzumab) | Details |
| Anti-CD83 Reference Antibody (Genentech patent anti-CD83) | Details |
| Anti-CD9 Reference Antibody (Genentech patent anti-CD9) | Details |
| Anti-CD98 Reference Antibody (KHK2898) | Details |
| Anti-CDCP1 / CD318 Reference Antibody (U.California patent anti-CDCP1) | Details |
| Anti-CDH1 / E-cadherin / CD324 Reference Antibody (Stem Centrx patent anti-Cadherin-1) | Details |
| Anti-CDH11 / Cadherin-11 Reference Antibody (RG6125) | Details |
| Anti-CDH3 / P-cadherin Reference Antibody (PF-03732010) | Details |
| Anti-CDH6 / K-Cadherin Reference Antibody (DS-6000a) | Details |
| Anti-CDH6 / K-Cadherin Reference Antibody (HKT288) | Details |
| Anti-Cdiff Toxin A Reference Antibody (actoxumab) | Details |
| Anti-CEACAM1 / CD66a Reference Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1) | Details |
| Anti-CEACAM1 / CD66a Reference Antibody (CM-24) | Details |
| Anti-CEACAM5 / CEA / CD66e Reference Antibody (cergutuzumAb) | Details |
| Anti-CEACAM5 / CEA / CD66e Reference Antibody (Immunomedics patent anti-CEACAM5 (Class III)) | Details |
| Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab) | Details |
| Anti-CEACAM5 / CEA / CD66e Reference Antibody (tusamitamab) | Details |
| Anti-CEACAM6 / CD66c Reference Antibody (NEO-201) | Details |
| Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab) | Details |
| Anti-CHI3L1 Reference Antibody (Brown U. patent anti-CHI3L1) | Details |
| Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain) | Details |
| Anti-CD52 Reference Antibody (gatralimab) | Details |
| Anti-CD59 Reference Antibody (Mellitus patent anti-CD59) | Details |
| Anti-CD59 Reference Antibody (Quark patent anti-CD59) | Details |
| Anti-CD6 Reference Antibody (itolizumab) | Details |
| Anti-CD69 Reference Antibody (Genefrontier patent anti-CD69) | Details |
| Product Total： Product Page： | ||||
| 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 | ||||